Scarica l'app Stockscreener
14.84
1.66%
-0.25
Precedente Chiudi:
$15.09
Aprire:
$14.96
Volume 24 ore:
287.26K
Relative Volume:
1.53
Capitalizzazione di mercato:
$1.17B
Reddito:
-
Utile/perdita netta:
$-46.13M
Rapporto P/E:
-18.27
EPS:
-0.8123
Flusso di cassa netto:
$-34.10M
1 W Prestazione:
-3.64%
1M Prestazione:
-14.24%
6M Prestazione:
-14.76%
1 anno Prestazione:
+37.03%
Intervallo 1D:
$14.69
$15.33
Intervallo di 1 settimana:
$14.69
$15.45
Portata 52W:
$10.76
$25.00
Pulse Biosciences Inc Stock (PLSE) Company Profile
Nome
Pulse Biosciences Inc
Settore
Industria
Telefono
510-906-4600
Indirizzo
3957 POINT EDEN WAY, HAYWARD, CA
Confronta PLSE con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
PLSE
Pulse Biosciences Inc
|
14.84 | 1.17B | 0 | -46.13M | -34.10M | -0.8123 |
|
ISRG
Intuitive Surgical Inc
|
537.99 | 189.82B | 8.71B | 2.48B | 1.75B | 6.82 |
|
BDX
Becton Dickinson Co
|
177.67 | 49.98B | 20.87B | 1.50B | 2.59B | 5.24 |
|
ALC
Alcon Inc
|
89.02 | 44.00B | 9.93B | 1.12B | 1.58B | 2.25 |
|
RMD
Resmed Inc
|
256.26 | 37.05B | 5.02B | 1.31B | 1.56B | 8.91 |
|
WST
West Pharmaceutical Services Inc
|
222.42 | 16.36B | 2.90B | 467.20M | 306.90M | 6.37 |
Pulse Biosciences Inc Stock (PLSE) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2021-07-27 | Iniziato | Stephens | Overweight |
| 2021-03-11 | Iniziato | Maxim Group | Buy |
| 2021-01-26 | Reiterato | H.C. Wainwright | Buy |
| 2020-05-12 | Aggiornamento | H.C. Wainwright | Neutral → Buy |
| 2020-02-14 | Downgrade | H.C. Wainwright | Buy → Neutral |
| 2019-02-25 | Iniziato | H.C. Wainwright | Buy |
Mostra tutto
Pulse Biosciences Inc Borsa (PLSE) Ultime notizie
Insider Sell: Darrin Uecker Sells 30,000 Shares of Pulse Bioscie - GuruFocus
Pulse Biosciences, Inc. (NASDAQ:PLSE) Shares Bought by UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC - Defense World
Nuveen Asset Management LLC Has $990,000 Stock Position in Pulse Biosciences, Inc. (NASDAQ:PLSE) - Defense World
BNP Paribas Financial Markets Has $35,000 Holdings in Pulse Biosciences, Inc. (NASDAQ:PLSE) - Defense World
Deutsche Bank AG Boosts Position in Pulse Biosciences, Inc. (NASDAQ:PLSE) - Defense World
Pulse Biosciences Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)May 23, 2025 - BioSpace
Pulse Biosciences Announces Inducement Grants Under Nasdaq Listi - GuruFocus
Bank of America Corp DE Has $13.73 Million Position in Pulse Biosciences, Inc. (NASDAQ:PLSE) - Defense World
Pulse Biosciences, Inc. (NASDAQ:PLSE) insiders have significant skin in the game with 73% ownership - Yahoo Finance
(PLSE) Proactive Strategies - news.stocktradersdaily.com
Tower Research Capital LLC TRC Has $29,000 Stock Position in Pulse Biosciences, Inc. (NASDAQ:PLSE) - Defense World
Transcript : Pulse Biosciences, Inc. Presents at BofA Securities 2025 Healthcare Conference, May-14-2025 05 - marketscreener.com
Pulse Biosciences, Inc. (NASDAQ:PLSE) Q1 2025 Earnings Call Transcript - Insider Monkey
Pulse Biosciences Earnings Call: Progress and Challenges - TipRanks
Barclays PLC Raises Stake in Pulse Biosciences, Inc. (NASDAQ:PLSE) - Defense World
Pulse Biosciences Reports Q1 2025 Financial Results - TipRanks
Pulse Biosciences Inc (PLSE) Q1 2025 Earnings Call Highlights: Strategic Advances Amid ... - Yahoo Finance
Wells Fargo & Company MN Purchases 2,416 Shares of Pulse Biosciences, Inc. (NASDAQ:PLSE) - Defense World
Pulse Biosciences Inc (PLSE) Q1 2025 Earnings Call Highlights: Strategic Advances Amid Financial Challenges - GuruFocus
Decoding Pulse Biosciences Inc (PLSE): A Strategic SWOT Insight - GuruFocus
Pulse Biosciences Reports Business Updates and First Quarter 2025 Financial Results - BioSpace
Earnings Flash (PLSE) Pulse Biosciences Q1 Loss $0.25 Vs. $0.18 Loss Year Ago - marketscreener.com
Earnings call transcript: Pulse Biosciences reports Q1 2025 loss, stock edges up - Investing.com
PULSE BIOSCIENCES, INC. SEC 10-Q Report - TradingView
Pulse Biosciences Inc Reports Q1 2025 Financial Results: GAAP Net Loss of $16.8 Million, Cash Reserves at $119.3 Million - GuruFocus
Concerns Raised Over Pulse Biosciences' (PLSE) Nano-Pulse Techno - GuruFocus
Pulse Biosciences To Present at the BofA Securities 2025 Health Care Conference - Business Wire
Pulse Biosciences (PLSE) Faces Criticism Over Technology's Past Performance | PLSE Stock News - GuruFocus
PLSE Faces Skepticism over Nano-Pulse Stimulation's Commercial V - GuruFocus
Concerns Raised Over Pulse Biosciences' (PLSE) Nano-Pulse Technology | PLSE Stock News - GuruFocus
After the recent decline, Pulse Biosciences, Inc. (NASDAQ:PLSE) Top Key Executive Robert Duggan's holdings have lost 4.2% of their value - simplywall.st
Pulse Biosciences names Jon Skinner as new CFO - MSN
Pulse Biosciences’ Nanosecond PFA Technology to be Featured at The American Association for Thoracic Surgery 2025 Annual Meeting - Stock Titan
Pulse Biosciences, Inc. (NASDAQ:PLSE) Shares Bought by Legal & General Group Plc - Defense World
Head to Head Survey: Pulse Biosciences (NASDAQ:PLSE) & Sight Sciences (NASDAQ:SGHT) - Defense World
Pulse Biosciences, Inc. (NASDAQ:PLSE) Shares Purchased by Invesco Ltd. - Defense World
Investor Network: Pulse Biosciences, Inc. to Host Earnings Call - ACCESS Newswire
Pulse Biosciences Schedules First Quarter 2025 Financial Results Conference Call for May 8, 2025 - BioSpace
Geode Capital Management LLC Increases Stock Holdings in Pulse Biosciences, Inc. (NASDAQ:PLSE) - Defense World
Press Release Distribution & PR Platform - ACCESS Newswire
Pulse Biosciences Schedules First Quarter 2025 Financial Results Conference Call for May 8, 2025 | PLSE Stock News - GuruFocus
Pulse Biosciences (NASDAQ:PLSE) Is In A Strong Position To Grow Its Business - Yahoo Finance
Pulse Biosciences’ Nanosecond PFA Technology to be Featured at The Heart Rhythm Society 2025 Annual Meeting - The Joplin Globe
Revolutionary Nanosecond PFA Heart Treatment Takes Center Stage at HRS 2025: J&J Partnership Revealed - Stock Titan
Pulse Biosciences Inc Azioni (PLSE) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Pulse Biosciences Inc Azioni (PLSE) insider trading
| Commercio interno | Relazione | Data | Transazione | Costo | #Azioni | Valore ($) | #Azioni Totale |
|---|---|---|---|---|---|---|---|
| UECKER DARRIN | Chief Technology Officer |
Jun 13 '25 |
Sale |
15.98 |
15,000 |
239,700 |
122,872 |
2.70%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):